The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

A groundbreaking study has revealed that the immune system plays a crucial role in determining the survival chances of cancer ...

Yun-Hsin Liu, Research Assistant at the UCL Cancer Institute, and co-first author, said, "We wanted to build on the previous work developing ORACLE and show that it can predict survival at the ...

The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust.

Professor John Bridgewater, UCL Cancer Institute clinical researcher and UCLH consultant medical oncologist, who will lead the UK arm of the trial, said: "These cancers are becoming more common.

A lung tumour analysis test can better predict patients’ survival chances at the point of diagnosis, a study suggests. While current methods for sampling cancers typically capture less than 1% ...

Together with University College London (UCL), King's College London (KCL) and the Francis Crick Institute, the BCI is a key partner in the Cancer Research UK (CRUK) City of London Centre, a ...

HIT-Meso is a clinical trial led by Consultant Clinical Oncologist, Dr Crispin Hiley and based at the UCL Cancer Institute. You can see details of the main clinical trial on the UCL website. HIT-Meso ...

as well as an Associate Professor/Principal Clinical Research Fellow at the UCL Cancer Institute ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...